Validations: Continuous Manufacturing & PAT / Real-Time Release
RTRT in Aseptic/Parenterals: Specific Challenges and Controls Real-time release testing (RTRT) in the context of aseptic and parenteral manufacturing represents a significant advancement in pharmaceutical validation strategies. As regulatory agencies such as the FDA and the EMA embrace innovative approaches to quality assurance, understanding the implications of implementing RTRT within the framework of continuous manufacturing processes becomes crucial for professionals…
Data Rights & E-Records: Who Owns Release Data? In the evolving landscape of pharmaceutical manufacturing, particularly within the domains of real-time release testing (RTRT), process analytical technology (PAT), and continuous manufacturing (CM), understanding data rights becomes crucial. This guide will take a deep dive into the complexities surrounding data ownership and e-records in the pharmaceutical industry, supplemented with regulatory guidance…
Release by Exception: When Evidence Is Still Sufficient Release by Exception: When Evidence Is Still Sufficient The pharmaceutical industry is evolving, particularly with the advent of advanced manufacturing techniques like continuous manufacturing and process analytical technology (PAT). In this landscape, real-time release testing (RTRT) emerges as a vital strategy, allowing for expedited, data-driven release decisions. This tutorial provides a comprehensive…
Batch Definition for RTRT in CM: Time/RTD-Based Claims The pharmaceutical industry is experiencing a paradigm shift with the advent of continuous manufacturing (CM) and real-time release testing (RTRT). These modern approaches facilitate rapid product availability while maintaining rigorous compliance with regulatory standards set forth by authorities like the FDA, EMA, and MHRA. This article aims to provide a comprehensive guide…
Documentation Sets for RTRT: What Auditors Ask First Continuous manufacturing and Real-Time Release Testing (RTRT) represent a paradigm shift in the pharmaceutical industry, driven by the need for efficiency and quality assurance. With increasing reliance on Process Analytical Technology (PAT) and the regulatory scrutiny associated with it, pharmaceutical professionals must prepare adequate documentation sets for RTRT to meet expectations laid…
RTRT Storyboards for Inspections: Clear Narratives and Cross-Refs RTRT Storyboards for Inspections: Clear Narratives and Cross-Refs The pharmaceutical industry is continually evolving to meet the rigorous expectations of regulatory bodies such as the FDA, EMA, and MHRA. One significant area of innovation in this space is Real-Time Release Testing (RTRT). As organizations adopt continuous manufacturing and Process Analytical Technology (PAT),…
Change Control for RTRT Rules: Verification vs Re-Validation Change Control for RTRT Rules: Verification vs Re-Validation The landscape of pharmaceutical manufacturing is continually evolving, particularly within the framework of Real-Time Release Testing (RTRT). This change, driven by advancements in Process Analytical Technology (PAT) and a push for continuous manufacturing, necessitates a robust understanding of change control mechanisms. Specifically, the dichotomy…
Handling Anomalies During RTRT: Diversion vs Downgrade Handling Anomalies During RTRT: Diversion vs Downgrade In an increasingly complex pharmaceutical manufacturing landscape, Real-Time Release Testing (RTRT) has emerged as a critical practice within continuous manufacturing processes. The adoption of RTRT, supported by Process Analytical Technology (PAT), ensures timely release of product while maintaining compliance with stringent regulatory standards set forth by…
Surrogate Measurements: Justification and Ongoing Verification Surrogate Measurements: Justification and Ongoing Verification In a pharmaceutical environment governed by stringent regulatory expectations from agencies such as the FDA, EMA, MHRA, and PIC/S, the evolution of manufacturing methodologies is pivotal. The advent of Continuous Manufacturing (CM) and Process Analytical Technology (PAT) demands a comprehensive understanding of surrogate measurements and their implications on…
Spec Setting with PAT: Guardbands and Consumer Risk In the rapidly evolving landscape of pharmaceutical manufacturing, the integration of Process Analytical Technology (PAT) is becoming increasingly important, particularly in the context of continuous manufacturing and real-time release testing (RTRT). This article serves as a step-by-step tutorial guide to understanding the significance of guardbands in specification setting, the assessment of consumer…